200 related articles for article (PubMed ID: 26743478)
1. Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus.
Chan MP; Andea AA; Harms PW; Durham AB; Patel RM; Wang M; Robichaud P; Fisher GJ; Johnson TM; Fullen DR
Mod Pathol; 2016 Mar; 29(3):227-39. PubMed ID: 26743478
[TBL] [Abstract][Full Text] [Related]
2. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
[TBL] [Abstract][Full Text] [Related]
3. Melanoma ex blue nevus: two cases resembling large plaque-type blue nevus with subcutaneous cellular nodules.
North JP; Yeh I; McCalmont TH; LeBoit PE
J Cutan Pathol; 2012 Dec; 39(12):1094-9. PubMed ID: 23145498
[TBL] [Abstract][Full Text] [Related]
4. SF3B1 and BAP1 mutations in blue nevus-like melanoma.
Griewank KG; Müller H; Jackett LA; Emberger M; Möller I; van de Nes JA; Zimmer L; Livingstone E; Wiesner T; Scholz SL; Cosgarea I; Sucker A; Schimming T; Hillen U; Schilling B; Paschen A; Reis H; Mentzel T; Kutzner H; Rütten A; Murali R; Scolyer RA; Schadendorf D
Mod Pathol; 2017 Jul; 30(7):928-939. PubMed ID: 28409567
[TBL] [Abstract][Full Text] [Related]
5. Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
Möller I; Murali R; Müller H; Wiesner T; Jackett LA; Scholz SL; Cosgarea I; van de Nes JA; Sucker A; Hillen U; Schilling B; Paschen A; Kutzner H; Rütten A; Böckers M; Scolyer RA; Schadendorf D; Griewank KG
Mod Pathol; 2017 Mar; 30(3):350-356. PubMed ID: 27934878
[TBL] [Abstract][Full Text] [Related]
6. Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma.
Held L; Eigentler TK; Metzler G; Leiter U; Messina JL; Glass LF; Garbe C; Bauer J
Am J Pathol; 2013 Mar; 182(3):640-5. PubMed ID: 23261261
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic and mutational analysis of a case of blue nevus-like melanoma.
Dai J; Tetzlaff MT; Schuchter LM; Elder DE; Elenitsas R
J Cutan Pathol; 2016 Sep; 43(9):776-80. PubMed ID: 27152652
[TBL] [Abstract][Full Text] [Related]
8. Melanoma Ex Blue Nevus With GNA11 Mutation and BAP1 Loss: Case Report and Review of the Literature.
Chang LW; Kazlouskaya V; Kazi R; Davar D; Ferris RL; Ho J; Karunamurthy A; Jedrych JJ; Bunimovich YL
Am J Dermatopathol; 2020 Nov; 42(11):854-857. PubMed ID: 32310862
[TBL] [Abstract][Full Text] [Related]
9. Mutations in GNA11 in uveal melanoma.
Van Raamsdonk CD; Griewank KG; Crosby MB; Garrido MC; Vemula S; Wiesner T; Obenauf AC; Wackernagel W; Green G; Bouvier N; Sozen MM; Baimukanova G; Roy R; Heguy A; Dolgalev I; Khanin R; Busam K; Speicher MR; O'Brien J; Bastian BC
N Engl J Med; 2010 Dec; 363(23):2191-9. PubMed ID: 21083380
[TBL] [Abstract][Full Text] [Related]
10. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.
Bender RP; McGinniss MJ; Esmay P; Velazquez EF; Reimann JD
Mod Pathol; 2013 Oct; 26(10):1320-8. PubMed ID: 23599145
[TBL] [Abstract][Full Text] [Related]
11. Blue Nevi and Related Tumors.
Zembowicz A
Clin Lab Med; 2017 Sep; 37(3):401-415. PubMed ID: 28802492
[TBL] [Abstract][Full Text] [Related]
12. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.
Bastian BC
Oncogene; 2003 May; 22(20):3081-6. PubMed ID: 12789284
[TBL] [Abstract][Full Text] [Related]
13. Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases.
Hung T; Argenyi Z; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Piepkorn MW; Prieto VG; Rabkin MS; Schmidt B; Selim MA; Shea CR; Trotter MJ; Barnhill RL
Am J Dermatopathol; 2016 Jul; 38(7):499-503. PubMed ID: 26909585
[TBL] [Abstract][Full Text] [Related]
14. Classifying melanocytic tumors based on DNA copy number changes.
Bastian BC; Olshen AB; LeBoit PE; Pinkel D
Am J Pathol; 2003 Nov; 163(5):1765-70. PubMed ID: 14578177
[TBL] [Abstract][Full Text] [Related]
15. Genomic analysis of blue nevi and related dermal melanocytic proliferations.
Maize JC; McCalmont TH; Carlson JA; Busam KJ; Kutzner H; Bastian BC
Am J Surg Pathol; 2005 Sep; 29(9):1214-20. PubMed ID: 16096412
[TBL] [Abstract][Full Text] [Related]
16. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
17. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").
Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ
Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768
[TBL] [Abstract][Full Text] [Related]
18. Melanoma arising in plaque-type blue nevus and dermal melanocytosis: Diagnostic and prognostic value of BAP1.
Requena C; Traves V; Ferrandis E; Antón Almero M; García-Casado Z; Manrique-Silva E; Santos Briz Á; Escalonilla P; Nagore E
Actas Dermosifiliogr; 2023; 114(7):636-641. PubMed ID: 37088284
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
